Could a simple blood test tell some breast cancer patients It's safe to stop treatment?
Knowledge-focused
Ongoing
This study is for people with HER2-positive metastatic breast cancer who have had a lasting response (complete or partial remission for over 2 years) on anti-HER2 therapy. Researchers will use a personalized blood test called Signatera to look for tiny amounts of cancer DNA. The …
Sponsor: Nagoya City University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC